Recent News

By Category: Research

Pentagon To Develop Q Fever Vaccine; U.S. Military To Focus On Biological Weapons Defense

(MedicalDaily) Next month, the Pentagon will host a seminar for researchers interested in developing a vaccine for the virus that causes Q fever, an animal-borne illness “weaponized” first by the U.S. and then the Soviet Union decades ago.

November 18, 2013
| Filed under Europe, North America, Biosafety, Bioterrorism, and Research
Share

Anthrax bacteria play hide and seek

(EurekaAlert) An EPFL team discovers that, using exosomes, the lethal factor of the anthrax bacterium can travel undetected through the body for days. The bacterium responsible for anthrax develops a strategy reminiscent of the Trojan horse tale. Its pathogenic factor is able to penetrate inside a cell in such a way that it becomes completely Read More »

November 15, 2013
| Filed under Europe, North America, Agents & Toxins, Bioterrorism, and Research
Share

NIH Scientists Develop Candidate Vaccine for RSV

(GlobalBiodefense) An experimental vaccine to protect against respiratory syncytial virus (RSV), a leading cause of illness and hospitalization among very young children, elicited high levels of RSV-specific antibodies when tested in animals, according to a recent report in the published in the journal Science. Early-stage human clinical trials of the candidate vaccine are planned.

November 11, 2013
| Filed under North America, Public Health, and Research
Share

Japanese fund to invest in promising technology against malaria, tuberculosis and Chagas disease

(EurekaAlert) The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, announced today grants of US$5.7 million to six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease.

November 8, 2013
| Filed under Asia/Pacific, North America, International, Public Health, and Research
Share

D.C.’s Public Health Laboratory Gets Federal Approval to Open Region’s First Biosafety Level 3 Lab

(LabManager) The District has received approval from the Centers for Disease Control and Prevention to begin operations at the first Biosafety Level 3 laboratory in the national capital region, Department of Forensic Sciences Director Max Houck announced. That means the city’s Public Health Laboratory can now conduct biological analysis that will identify dozens of materials Read More »